Select a Month...
Solid Tumors Targeted in New CAR T-Cell Immunotherapy Trial
Open to children and young adults with relapsed or refractory disease, clinical trial extends immunotherapy to several types of EGFR-expressing solid tumors
Seattle Children’s Announces New Odessa Brown Children’s Clinic to Better Serve the Needs of the Community
Seattle Children’s new Odessa Brown Children’s Clinic will be located in South Seattle to increase access to healthcare for lower-income families who have...
Center for Infectious Disease Research to Join Seattle Children’s Research Institute
Combined scientific team will form largest pediatric infectious disease research program in the U.S.
Seattle Children’s Names Building in Honor of Friends of Costco
Friends of Costco has raised $125 Million for uncompensated care at Seattle Children’s
Seattle Children's Opens Immunotherapy Trial for Children With Relapsed Central Nervous System Tumors That Delivers CAR T Cells Directly Into the Brain
CAR T-cell immunotherapy targeting HER2 protein on cancer cells aims to provide children and young adults who have limited treatment options with a second line...
CureWorks Collaborative Launches to Accelerate Development of Immunotherapy Treatments for Childhood Cancers, Increase Access to Clinical Trials
Seattle Children’s, Children’s National Health System, BC Children’s Hospital and Children's Hospital Los Angeles start international collaborative to expand...
Seattle Children’s Receives $60 Million Legacy Gift
The landmark bequest is the second largest single charitable gift in Seattle Children’s 111-year history
Immunotherapy Drug for Rheumatoid Arthritis Nearly Eliminates Severe Acute Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplant
The drug Abatacept (Orencia) nearly eliminated life-threatening severe acute graft-versus-host disease (GvHD) in patients receiving hematopoietic stem cell...
Brotman Baty Institute for Precision Medicine Launches in Seattle
The Brotman Baty Institute for Precision Medicine combines the research strengths and capabilities of UW Medicine, Fred Hutchinson Cancer Research Center and...
Seattle Children’s Opens First CAR T-Cell Immunotherapy Trial in the U.S. for Children and Young Adults With Leukemia That Targets CD22 and CD19 Proteins Simultaneously
By launching a bilateral attack on cancer cells, researchers hope to ultimately increase patients’ long-term remission